Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Lambrecht

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Diagnostics (Basel, Switzerland)|February 13, 2026
Long-Term Follow-Up in Patients with Large-Vessel Vasculitis Applying Extracranial and Transcranial Duplex SonographyJohanna Härtl, Sebastian Lambrecht, Felix Hess, et al.
Therapeutic Advances in Neurological Disorders|October 6, 2025
Increased middle cerebral artery velocity predicts malignant media infarction after endovascular stroke thrombectomyEnayatullah Baki, Victoria Kehl, Marlene Topka, et al.
AJNR. American Journal of Neuroradiology|April 7, 2025
Deep learning-based generation of DSC MRI parameter maps using DCE MRI dataHaoyang Pei, Yixuan Lyu, Sebastian Lambrecht, et al.
Brain Sciences|February 23, 2024
Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast PerfusionSebastian Lambrecht, Dapeng Liu, Omar Dzaye, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 17, 2025
Predictors of early disability accumulation in newly diagnosed multiple sclerosis: clinical, imaging and cerebrospinal fluid measuresMarkus Lauerer, Tun Wiltgen, Carolin Brückner, et al.
Journal of Neuro-Oncology|October 18, 2019
White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.
Journal of Neuro-Oncology|November 24, 2019
Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Diagnostics (Basel, Switzerland)|February 13, 2026
Long-Term Follow-Up in Patients with Large-Vessel Vasculitis Applying Extracranial and Transcranial Duplex SonographyJohanna Härtl, Sebastian Lambrecht, Felix Hess, et al.
Therapeutic Advances in Neurological Disorders|October 6, 2025
Increased middle cerebral artery velocity predicts malignant media infarction after endovascular stroke thrombectomyEnayatullah Baki, Victoria Kehl, Marlene Topka, et al.
AJNR. American Journal of Neuroradiology|April 7, 2025
Deep learning-based generation of DSC MRI parameter maps using DCE MRI dataHaoyang Pei, Yixuan Lyu, Sebastian Lambrecht, et al.
Brain Sciences|February 23, 2024
Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast PerfusionSebastian Lambrecht, Dapeng Liu, Omar Dzaye, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 17, 2025
Predictors of early disability accumulation in newly diagnosed multiple sclerosis: clinical, imaging and cerebrospinal fluid measuresMarkus Lauerer, Tun Wiltgen, Carolin Brückner, et al.
Journal of Neuro-Oncology|October 18, 2019
White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.
Journal of Neuro-Oncology|November 24, 2019
Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximabFayez Estephan, Xiaobu Ye, Omar Dzaye, et al.
Pageof 1